Jacob E. Berchuck, MD

Background

Jacob Berchuck, MD, is a board-certified medical oncologist specializing in the treatment of genitourinary cancers. Dr. Berchuck is an attending physician at Winship Cancer Institute of Emory University and an assistant professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine. Before joining Emory in 2024, Dr. Berchuck was an assistant professor of medicine at Harvard Medical School and a medical oncologist at the Dana-Farber Cancer Institute.

Dr. Berchuck earned his MD from Duke University in Durham, North Carolina. He completed his residency in internal medicine at the University of California, San Francisco, and his fellowship in medical oncology, along with a postdoctoral research fellowship, at Dana-Farber Cancer Institute/Harvard Medical School.
 

Titles & Roles

• Assistant Professor, Department of Hematology and Medical Oncology

  Emory University School of Medicine

Education & Training

Education

• Fellowship, Hematology/Oncology, 2020

  Dana-Farber Cancer Institute
• Gap in Credential/List explanation in comments, 2017

  GAP in Education. List details in comments
• Residency, Internal Medicine, 2016

  UCSF School of Medicine
• Internship, Internal Medicine, 2014

  UCSF School of Medicine
• Medical Education, MD, 2013

  Duke University School of Medicine

Board Certifications

• Medical Oncology

  American Board of Internal Medicine, 2020
• Internal Medicine

  American Board of Internal Medicine, 2016

Professional Memberships

• American Society of Clinical Oncology
• American Association of Cancer Research

Research

Dr. Berchuck’s research focuses on developing biomarkers to guide treatment decisions, deciphering mechanisms of treatment resistance and discovering novel therapeutic strategies. His research utilizes “liquid biopsies” — studying tumor biology by profiling cell-free DNA circulating in the bloodstream — aiming for a future where a simple blood draw can provide real-time insights to choose the right treatment for the right patient at the right time.

Publications

Dr. Berchuck’s research has been published in several leading journals, including Nature Medicine, Cancer Cell, Annals of Oncology, JAMA Oncology, European Urology, and Clinical Cancer Research.

Ratings & Reviews

Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care. Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful for our patients, please click here.